CLINICAL_TRIALS
trial_result
· 2007-12-06
Clinical Trial Update: Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis [Phase 3]
Summary
A Phase 3 trial evaluating the safety and efficacy of Etanercept 50 mg once weekly for psoriasis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Psoriasis | Phase 3 | Status: COMPLETED